FBRX

Forte Biosciences Inc

NASDAQ: FBRX · HEALTHCARE · BIOTECHNOLOGY

$24.29

-1.02% today

Updated 2026-06-05

Market cap

$338.31M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.58

Dividend yield

—

52W range

$9 – $36

Volume

0.3M

Market cap

$338.31M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.58

Dividend yield

—

52W range

$9 – $36

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.3

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-4.1

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$63.75

+162.45%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -4.05 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-18.81M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-13.86M	$-31.48M	$-35.48M	$-69.38M	$-22.14M
EPS	—	—	—	—	$-4.58
Free cash flow	$-8.19M	$-28.79M	$-30.78M	$-51.00M	$-18.81M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-04-01	WAGNER, PAUL A.	Sale	1,250	—
2026-04-01	WAGNER, PAUL A.	Buy	1,250	—
2026-04-01	WAGNER, PAUL A.	Sale	98	$24.86

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
FBRX	$338.31M	23	4.3	3.0	5.0	4.3	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Forte Biosciences Inc trades at $24.29. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -4.05, it sits in the distress.

Frequently asked questions

What is Forte Biosciences Inc's stock price?

Forte Biosciences Inc (FBRX) trades at $24.29.

Is Forte Biosciences Inc overvalued?

Forte Biosciences Inc carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Forte Biosciences Inc (FBRX)?

The 12-month analyst consensus target is $63.75, about 162.5% above the current $24.29. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Forte Biosciences Inc's Altman Z-Score is -4.05, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-180.18%

Beta2.87

50D MA$26.03

200D MA$22.01

Shares out0.02B

Float0.02B

Short ratio—

Avg volume0.3M

Performance

1 week+0.89%

1 month-26.48%

3 months-33.10%

YTD-29.45%

1 year—

3 years—

5 years—

Compare

FBRX vs LLY →FBRX vs JNJ →FBRX vs ABBV →Stock screener →